@article{3029633,
    title = "Atezolizumab (atezo) plus platinum/gemcitabine (plt/gem) vs placebo plus
plt/gem in patients (pts) with previously untreated locally advanced or
metastatic urothelial carcinoma (mUC): Updated overall survival (OS)
from the randomized phase III study IMvigor130.",
    author = "Galsky, Matthew D. and Arranz, Jose Angel and Grande, Enrique and De and Santis, Maria and Davis, Ian D. and Kikuchi, Eiji and Garcia del Muro, and Xavier and Park, Se Hoon and De Giorgi, Ugo and Alekseev, Boris and and Mencinger, Marina and Izumi, Kouji and Puente, Javier and Li, Jian-Ri and and O'Donnell, Peter H. and Shen, Xiaodong and Lee, Chooi and Mecke, and Almut and Mariathasan, Sanjeev and Bamias, Aristotelis",
    journal = "Clinical Cancer Research",
    year = "2021",
    volume = "81",
    number = "13, S",
    publisher = "AMER ASSOC CANCER RESEARCH",
    issn = "1078-0432",
    doi = "10.1158/1538-7445.AM2021-CT042"
}